Influenza
Authors: Christine Laine
Journal: Annals of Internal Medicine (2007)

In the Clinic2 October 2007InfluenzaChristine Laine, MD, MPH, David R. Goldman, MD, and Margaret Trexler Hessen, MDChristine Laine, MD, MPHSearch for more papers by this author, David R. Goldman, MDSearch for more papers by this author, and Margaret Trexler Hessen, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-147-7-200710020-01010 SectionsSupplemental MaterialAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Editor's Note: This issue of In the Clinic has been updated.Recent vaccine shortages, reports of human infection caused by avian strains, and the specter of pandemic disease have kept influenza in the public eye over the past few years. Even during a typical influenza season, the impact on public health, though less heralded, is significant. Influenza and its complications cause approximately 36 000 deaths and 226 000 hospitalizations per year (1). Safe, cost-effective vaccines are available but have been underutilized by both the public and health care workers because of widespread misconceptions about both the disease and the vaccines. ...References1. Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep. 2007;56:1-54. [PMID: 17625497] Google Scholar2. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med. 2003;348: 1322-32. [PMID: 12672859] Google Scholar3. Mangtani P, Cumberland P, Hodgson CR, Roberts JA, Cutts FT, et al. A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. J Infect Dis. 2004;190:1-10. [PMID: 15195237] Google Scholar4. Hak E, Buskens E, van Essen, GA, de Bakker DH, Grobbee DE, et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med. 2005;165:274-80. [PMID: 15710789] Google Scholar5. Potter J, Stott DJ, Roberts MA, Elder AG, O'Donnell B, et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis. 1997;175:1-6. [PMID: 8985189] Google Scholar6. Carman WF, Elder AG, Wallace LA, McAulay K, Walker A, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet. 2000;355:93-7. [PMID: 10675165] Google Scholar7. Hayward AC, Harling R, Wetten S, Johnson AM, Munro S, et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ. 2006;333:1241. [PMID: 17142257] Google Scholar8. Ohmit SE, Victor JC, Rotthoff JR, Teich ER, Truscon RK, et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med. 2006;355:2513-22. [PMID: 17167134] Google Scholar9. LaMontagne JR, Noble GR, Quinnan GV, et al. Summary of clinical trials of inactivated influenza vaccine-1978. Rev Infect Dis. 1983;5:723-36. [PMID: 6353529] Google Scholar10. Lo W, Whimbey E, Elting L, Couch R, Cabanillas F, et al. Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy. Eur J Clin Microbiol Infect Dis. 1993;12:778-82. [PMID: 8307050] Google Scholar11. Engelhard D, Nagler A, Hardan I, Morag A, Aker M, et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant. 1993;11:1-5. [PMID: 8431706] Google Scholar12. Soesman NM, Rimmelzwaan GF, Nieuwkoop NJ, Beyer WE, Tilanus HW, et al. Efficacy of influenza vaccination in adult liver transplant recipients. J Med Virol. 2000;61:85-93. [PMID: 10745238] Google Scholar13. Nichol KL, Mendelman PM, Mallon KP, Jackson LA, Gorse GJ, et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA. 1999;282:137-44. [PMID: 10411194] Google Scholar14. King JC Jr., Stoddard JJ, Gaglani, et al. Effectiveness of school-based influenza vaccination. N Engl J Med. 2006;355:2523-32. (PMID: 17167135). Google Scholar15. Monto AS, Robinson DP, Herlocher ML, Hinson JM Jr., Elliott MJ, et al. Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial. JAMA. 1999;282:31-5. [PMID: 10404908] Google Scholar16. Welliver R, Monto AS, Carewicz O. Effectiveness of oseltamavir in preventing influenza in household contacts: a randomized controlled trial. JAMA. 2001;285:748-54. [PMID: 11176912] Google Scholar17. Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner D, et al. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomized controlled trials. BMJ. 2003;326:1235. [PMID: 12791735] Google Scholar18. Zanamivir Family Study Group. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group. N Engl J Med. 2000;343:1282-9. [PMID: 11058672] Google Scholar19. Hayden FG, Atmar RL, Schilling M, Johnson C, Poretz D, et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med. 1999;341:1336-43. [PMID: 10536125] Google Scholar20. Hayden FG, Belshe R, Villanueva C, Lanno R, Hughes C, et al. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. J Infect Dis. 2004;189:440-9. [PMID: 14745701] Google Scholar21. Fedson DS, Houck P, Bratzler D. Hospital-based influenza and pneumococcal vaccination: Sutton's law applied to prevention. Infect Control Hosp Epidemiol. 2006; 21:692-9. [MID:11089652] Google Scholar22. Zambon M, Hays J, Webster A, Newman R, Keene O. Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza. Arch Intern Med. 2001;161:2116-22. [PMID: 11570941] Google Scholar23. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000;160:3243-7. [PMID: 11088084] Google Scholar24. Falsey AR, Murata Y, Walsh EE. Impact of rapid diagnosis on management of adults hospitalized with influenza. Arch Intern Med. 2007;167:354-60. [PMID: 17242309] Google Scholar25. Connolly AM, Salmon RL, Lervy B, Williams DH. What are the complications of influenza and can they be prevented? Experience from the 1989 epidemic of H3N2 influenza A in general practice. BMJ. 1993;306:1452-4. [PMID: 8518643] Google Scholar26. Treanor JJ, Hayden FG, Vrooman PS, Barbarash R, Bettis R, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA. 2000;283:1016-24. [PMID: 10697061] Google Scholar27. Nicholson KG, Aoki FY, Osterhaus AD, Trottier S, Carewicz O, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet. 2000;355:1845-50. [PMID: 10866439] Google Scholar28. Monto AS, Webster A, Keene O. Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis. J Antimicrob Chemother. 1999;44 Suppl B:23-9. [PMID: 10877459] Google Scholar29. Lalezari J, Campion K, Keene O, Silagy C. Zanamivir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials. Arch Intern Med. 2001;161:212-7. [PMID: 11176734] Google Scholar30. Hayden FG, Osterhaus AD, Treanor JJ, Fleming DM, Aoki FY, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Engl J Med. 1997;337:874-80. [PMID: 9302301] Google Scholar31. Mäkelä MJ, Pauksens K, Rostila T, Fleming DM, Man CY, et al. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study. J Infect. 2000;40:42-8. [PMID: 10762110] Google Scholar32. Kaiser L, Keene ON, Hammond JM, Elliott M, Hayden FG. Impact of zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults. Arch Intern Med. 2000;160:3234-40. [PMID: 11088083] Google Scholar33. Hayden FG, Lobo M, Hussey EK, et al. Efficacy of intranasal GG167 in experimental human influenza A and B virus infection. In: Brown LE, Hampson AW, Webster RG, eds. Options for the Control of Influenza III. Amsterdam: Elsevier; 1996:718-25. Google Scholar34. Hayden FG, Jennings L, Robson R, Schiff G, Jackson H, et al. Oral oseltamivir in human experimental influenza B infection. Antivir Ther. 2000;5:205-13. [PMID: 11075941] Google Scholar35. Centers for Medicare and Medicaid Services. Medicare and Medicaid Programs. Condition of participation: immunization standard for long-term care facilities. Final rule. Federal Register. 2005:70:194;58833-52. [PMID: 16211747] Google Scholar36. Finch M. Point: mandatory influenza vaccination for all heath care workers? Seven reasons to say "no". Clin Infect Dis. 2006;42:1141-3. [PMID: 16575732] Google Scholar37. Backer H. Counterpoint: in favor of mandatory influenza vaccine for all healthcare workers. Clin Infect Dis. 2006;42:1144-7. [PMID: 16575733] Google Scholar38. Talbot T, Bradley S, Cosgrove S, Ruef C, Siegel J, et al. Influenza Vaccination of Healthcare Workers and Vaccine Allocation for Healthcare Workers During Vaccine Shortages. Vanderbilt University Medical Center. Departments of Medicine and Preventive Medicine. Accessed at www.shea-online.org/Assets/files/HCW_Flu_Position_Paper_Final_9-28.pdf. Accessed 7/20/07). Google Scholar39. Pandemic and Seasonal Influenza Principles for U.S. Action. Alexandria, Virginia: Infectious Diseases Society of America; 2007. Accessed at www.idsociety.org/Content/NavigationMenu/News_Room1/Pandemic_and_Seasonal_Influenza?IDSA_flufinalAPPROVED1.24.07.pdf. Accessed on 7/20/07. Google Scholar Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 2 October 2007Volume 147, Issue 7Page: ITC10-1KeywordsChildrenDrugsFeversHealth care providersHospitalizationsInfectious diseasesNursing homesProphylaxisPulmonary diseasesVaccines ePublished: 2 October 2007 Issue Published: 2 October 2007 Copyright & PermissionsCopyright © 2007 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...